相似文献
1
Targeted nanoagents for the detection of cancers.
Mol Oncol. 2010 Dec;4(6):511-28. doi: 10.1016/j.molonc.2010.08.003. Epub 2010 Sep 8.
2
Applications of aptamers in targeted imaging: state of the art.
Curr Top Med Chem. 2015;15(12):1138-52. doi: 10.2174/1568026615666150413153400.
3
Aptamers: active targeting ligands for cancer diagnosis and therapy.
Theranostics. 2015 Jan 20;5(4):322-44. doi: 10.7150/thno.10257. eCollection 2015.
4
Aptamers in targeted nanotherapy.
Curr Top Med Chem. 2015;15(12):1102-14. doi: 10.2174/1568026615666150413153525.
5
Functional DNA-containing nanomaterials: cellular applications in biosensing, imaging, and targeted therapy.
Acc Chem Res. 2014 Jun 17;47(6):1891-901. doi: 10.1021/ar500078f. Epub 2014 Apr 29.
6
Supramolecular peptide nano-assemblies for cancer diagnosis and therapy: from molecular design to material synthesis and function-specific applications.
J Nanobiotechnology. 2021 Aug 23;19(1):253. doi: 10.1186/s12951-021-00999-x.
7
A review of NIR dyes in cancer targeting and imaging.
Biomaterials. 2011 Oct;32(29):7127-38. doi: 10.1016/j.biomaterials.2011.06.024. Epub 2011 Jul 2.
8
Aptamer-Enabled Nanomaterials for Therapeutics, Drug Targeting and Imaging.
Cells. 2022 Jan 4;11(1):159. doi: 10.3390/cells11010159.
9
Nanotechnology for targeted cancer therapy.
Expert Rev Anticancer Ther. 2007 Jun;7(6):833-7. doi: 10.1586/14737140.7.6.833.
10
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
Neuroimage. 2011 Jan;54 Suppl 1(Suppl 1):S106-24. doi: 10.1016/j.neuroimage.2010.01.105. Epub 2010 Feb 10.
引用本文的文献
1
Imaging ligands targeting glypican-3 receptor expression in hepatocellular carcinoma.
Am J Nucl Med Mol Imaging. 2022 Aug 20;12(4):113-121. eCollection 2022.
2
Development of Novel Tetrapyrrole Structure Photosensitizers for Cancer Photodynamic Therapy.
Bioengineering (Basel). 2022 Feb 19;9(2):82. doi: 10.3390/bioengineering9020082.
3
Chitosan overlaid FeO/rGO nanocomposite for targeted drug delivery, imaging, and biomedical applications.
Sci Rep. 2020 Nov 3;10(1):18912. doi: 10.1038/s41598-020-76015-3.
4
Preparation of a nitric oxide imaging agent from gelatin derivative micelles.
Regen Ther. 2016 Sep 14;5:64-71. doi: 10.1016/j.reth.2016.08.003. eCollection 2016 Dec.
5
Detecting GPC3-Expressing Hepatocellular Carcinoma with L5 Peptide-Guided Pretargeting Approach: In Vitro and In Vivo MR Imaging Experiments.
Contrast Media Mol Imaging. 2018 Sep 10;2018:9169072. doi: 10.1155/2018/9169072. eCollection 2018.
6
Immunological Approaches Towards Cancer and Inflammation: A Cross Talk.
Front Immunol. 2018 Mar 20;9:563. doi: 10.3389/fimmu.2018.00563. eCollection 2018.
7
Gold nanoparticle-based rapid detection and isolation of cells using ligand-receptor chemistry.
Sci Rep. 2018 Feb 13;8(1):2893. doi: 10.1038/s41598-018-21068-8.
8
Nanoparticle core stability and surface functionalization drive the mTOR signaling pathway in hepatocellular cell lines.
Sci Rep. 2017 Nov 22;7(1):16049. doi: 10.1038/s41598-017-16447-6.
9
Targeted Magnetic Nanotheranostics of Cancer.
Molecules. 2017 Jun 12;22(6):975. doi: 10.3390/molecules22060975.
10
NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?
J Nanobiotechnology. 2016 Mar 9;14:17. doi: 10.1186/s12951-016-0172-2.
本文引用的文献
1
Magnetic Nanoparticles for Early Detection of Cancer by Magnetic Resonance Imaging.
MRS Bull. 2009 Jun;34(6):441-448. doi: 10.1557/mrs2009.120.
2
Binding affinity and kinetic analysis of targeted small molecule-modified nanoparticles.
Bioconjug Chem. 2010 Jan;21(1):14-9. doi: 10.1021/bc900438a.
3
Bioconjugated quantum dots for cancer research: present status, prospects and remaining issues.
Biotechnol Adv. 2010 Mar-Apr;28(2):199-213. doi: 10.1016/j.biotechadv.2009.11.007. Epub 2009 Dec 5.
4
Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging.
Acta Radiol. 2009 Dec;50(10):1095-103. doi: 10.3109/02841850903008800.
5
Near-infrared fluorescence: application to in vivo molecular imaging.
Curr Opin Chem Biol. 2010 Feb;14(1):71-9. doi: 10.1016/j.cbpa.2009.09.029. Epub 2009 Oct 30.
6
Cancer nanotargeted radiopharmaceuticals for tumor imaging and therapy.
Anticancer Res. 2009 Oct;29(10):4107-18.
7
Imaging in targeted delivery of therapy to cancer.
Target Oncol. 2009 Sep;4(3):201-17. doi: 10.1007/s11523-009-0119-8. Epub 2009 Oct 8.
8
Optical imaging-guided cancer therapy with fluorescent nanoparticles.
J R Soc Interface. 2010 Jan 6;7(42):3-18. doi: 10.1098/rsif.2009.0243. Epub 2009 Sep 16.
9
Recent developments in carbohydrate-decorated targeted drug/gene delivery.
Med Res Rev. 2010 Mar;30(2):270-89. doi: 10.1002/med.20171.
10
Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors.
Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1444-51. doi: 10.1161/ATVBAHA.109.193086. Epub 2009 Jul 16.
Zotero 插件